These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7784730)

  • 1. Biological and protective activities of outer membrane proteins from Bordetella.
    González-y-Merchand J; Ruiloba de León S; Estrada-García I; López-Flores C; Ortega-Ortega R; Ruíz-Puente J
    Rev Latinoam Microbiol; 1995; 37(1):33-41. PubMed ID: 7784730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis.
    Brennan MJ; Li ZM; Shahin RD; Burns DL; Nguyen NY; Liu TY; Gray MC; Hewlett EL; Manclark CR
    Tokai J Exp Clin Med; 1988; 13 Suppl():211-5. PubMed ID: 2908522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.
    Novotny P; Chubb AP; Cownley K; Montaraz JA; Beesley JE
    Dev Biol Stand; 1985; 61():27-41. PubMed ID: 2872113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S; van Furth R; Mooi FR
    Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
    Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
    Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with outer membrane proteins of Pasteurella multocida (6:B) provides protection in mice.
    Basagoudanavar SH; Singh DK; Varshney BC
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):524-30. PubMed ID: 17105574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conversion of Bordetella parapertussis serovar through lysogeny produced by pertussis phages].
    Mebel S; Lapaeva I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):547-56. PubMed ID: 7180238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of outer membrane proteins of Riemerella antipestifer].
    Liu Y; Wei Q; Bao G; Ji Q
    Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):586-91. PubMed ID: 18616167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The purification and protective capacity of Bordetella pertussis outer membrane proteins.
    Hamstra HJ; Kuipers B; Schijf-Evers D; Loggen HG; Poolman JT
    Vaccine; 1995; 13(8):747-52. PubMed ID: 7483790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide.
    Brodeur BR; Hamel J; Martin D; Rondeau P
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):194-9. PubMed ID: 1721552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF; Chen CS; Palaniappan RU; He H; McDonough SP; Barr SC; Yan W; Faisal SM; Pan MJ; Chang CF
    Vaccine; 2007 Nov; 25(48):8190-7. PubMed ID: 17936448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
    Mills KH; Brady M; Ryan E; Mahon BP
    Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency assay and characterization of lymphocytosis promoting factor in whole cell and acellular pertussis vaccines.
    Tiru M; Falk A; Brym-Grynblat B; Pettersson IM
    Dev Biol Stand; 1991; 73():157-65. PubMed ID: 1778309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine-sensitizing factor, mouse-protective antigens, and other antigens of some members of the genus Bordetella.
    Ross R; Munoz J; Cameron C
    J Bacteriol; 1969 Jul; 99(1):57-64. PubMed ID: 4308413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.